
Shingles Vaccine Rollout Surprisingly Reduces Dementia
New research hints at a simple, widely available vaccine that may help protect brain health.

New research hints at a simple, widely available vaccine that may help protect brain health.

NEW RESEARCH: A diabetes medication already helping millions, called Jardiance, improves memory, strengthens blood flow, and supports overall brain health in pre- and early Alzheimer’s.

Stanford Medicine’s new analysis of a vaccination program found shingles vaccines appear to lower dementia diagnoses by 20% — more than any other known intervention.

In an Alzheimer’s study, insulin delivered high up in the nasal cavity achieved lasting results in improving memory. Find out why Dr. W. Banks calls this “one of those studies where everything is coming together.”

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

People with Parkinson’s were given the oral drug rivastigmine (brand name Exelon®). They were 45% less likely to fall and were considerably steadier when walking. Learn more about this dementia drug and fall prevention.

DRUGS: Long-term antibiotic treatment decreased Alzheimer’s-causing plaques in the lab. It also helped the brain fight inflammation by enhancing the neuroinflammatory activity of microglial cells.

GOOD NEWS: Donepezil (Aricept®), approved for Alzheimer’s, also passed a long-term trial for Dementia with Lewy Bodies (DLB). Get the details on the medicine’s positive

OFF-LABEL MEDICATIONS: Memantine (Namenda / Ebixa) is FDA-approved for Alzheimer’s. Learn how it significantly improves memory and attention in Lewy Body Disease, Parkinson’s and various

OFF-LABEL: An approved prescription drug for high blood pressure is showing promise against Parkinson’s, Huntington’s and other forms of dementia, in experimental studies in the

Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.

New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.

Strengthening social connections may offer a surprising boost to long-term brain health.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


